Drug Trial Radar · NCT06838676
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Last checked: Nov 19, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
60
Planned (sponsor's estimate)
Start
Jul 10, 2025
Primary completion
Jul 2028
Study completion Jul 2035
Sponsor
- Lead sponsor
- Nationwide Children's HospitalAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- Accendatech USA Inc.
- First posted
- Feb 21, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 12 months, up to 39 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase II open-label study to investigate the safety and efficacy of ACT001 in patients with DIPG and H3K27-altered HGG.
Conditions
- Diffuse Intrinsic Pontine Gliomas (DIPG)
- Progressive DIPG
- Refractory DIPG
- Recurrent DIPG
- H3K27-altered High Grade Glioma
Interventions
ACT001Drug
PO BID at 875 mg/m2 for 28 days
Primary outcomes
What the sponsor says the trial is designed to measure.
- Overall Survival (OS) for newly diagnosed DIPGTime frame: From date on treatment until date of death due to any cause or date of last follow-up, assessed up to 60 months
- Objective Response Rate (ORR) in Progressive/Refractory/Recurrent HGG after frontline RTTime frame: Date on treatment through 30 days following end of protocol treatment
Locations
20 sites in 5 countries. Site status is shown where the registry gives one.
Children's Hospital Colorado
Aurora, Colorado · Recruiting
Children's National Medical Center
Washington D.C., District of Columbia · Recruiting
Nicklaus Children's Hospital
Miami, Florida · Not yet recruiting
Emory University/Children's Healthcare of Atlanta
Atlanta, Georgia · Not yet recruiting
C.S. Mott Children's Hospital
Ann Arbor, Michigan · Recruiting
St. Louis Children's Hospital
St Louis, Missouri · Recruiting
Duke University Medical Center
Durham, North Carolina · Not yet recruiting
Cincinnati Children's Hospital
Cincinnati, Ohio · Recruiting
Nationwide Children's Hospital
Columbus, Ohio · Recruiting
Children's Hospital of Philidelphia
Philidelphia, Pennsylvania · Not yet recruiting
Texas Children's Hospital
Houston, Texas · Recruiting
Seattle Children's Hospital
Seattle, Washington · Recruiting
Sydney Children's Hospital
Randwick, New South Wales, Australia · Recruiting
Queensland Children's Hospital
South Brisbane, Queensland, Australia · Not yet recruiting
Royal Children's Hospital
Melbourne, Victoria, Australia · Not yet recruiting
Perth Children's Hospital
Perth, Western Australia, Australia · Not yet recruiting
The Hospital for Sick Children (SickKids)
Toronto, Ontario, Canada · Recruiting
Montreal Children's Hospital
Montreal, Quebec, Canada · Not yet recruiting
Hopp Children's Cancer Center at NCT Heidelberg (KiTZ)
Heidelberg, Baden-Wurttemberg, Germany · Not yet recruiting
Starship Children's Hospital
Auckland, Grafton, New Zealand · Not yet recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.